PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1532627
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1532627
Diagnostic Specialty Enzymes Market - Product (Polymerases and Nucleases, Proteases, Oxidases, Carbohydrase), Application (Clinical Chemistry [Blood Glucose Monitoring, POC Testing], Immunoassay, Molecular Diagnostics) - Global Forecast (2024 - 2032)
Diagnostic specialty enzymes market size is anticipated to observe an 8.1% CAGR from 2024 to 2032, driven by the increasing prevalence of chronic and infectious diseases that require precise and early detection. Reports indicate that 1 in 3 adults worldwide suffer from multiple chronic conditions. As the global population is aging and the incidence of diseases like cancer, diabetes, and cardiovascular conditions is rising, there is growing demand for advanced diagnostic tools that can provide accurate and rapid results.
Innovations in molecular diagnostics, personalized medicine, and point-of-care testing are also driving the demand for specialized enzymes to facilitate complex assays and improve diagnostic accuracy. The rise of home-based testing and the increasing focus on preventive healthcare are also driving the market expansion.
The diagnostic specialty enzymes industry is segmented into product, application, and region.
With respect to product, the oxidases segment is poised for substantial growth from 2024 to 2032. Oxidases play a pivotal role in a variety of high-precision diagnostic assays and biosensors, such as glucose monitoring in diabetes management as well as, detecting pathogens and metabolic disorders. Advancements in oxidase enzyme technology for enhancing stability and reaction specificity, coupled with the rising demand for point-of-care and home-based diagnostic solutions will further bolster the segment growth.
In terms of application, the diagnostic specialty enzymes market from the immunoassays segment will grow significantly through 2032 owing to its widespread application in detecting a variety of diseases and conditions with high specificity and sensitivity. Immunoassays, which rely on enzyme-linked immunosorbent assays (ELISA) and other enzyme-based detection methods, are crucial for accurate disease diagnosis and monitoring.
Asia Pacific diagnostic specialty enzymes industry is primed for significant expansion from 2024 to 2032. This growth is attributed to the increasing healthcare needs, the rising prevalence of chronic and infectious diseases, along with rapid advancements in diagnostic technologies. The focus on personalized medicine and the growing emphasis on early disease detection are also key drivers driving the regional product adoption.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definitions
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Growth in molecular diagnostic tests
- 3.2.1.2 Increasing demand for timely diagnosis of chronic diseases
- 3.2.1.3 Rapid adoption of point of care testing technologies
- 3.2.1.4 Advances in enzyme production technology
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Stringent regulatory requirements
- 3.2.2.2 Concerns related to product quality and safety
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Future market trends
- 3.5 Regulatory landscape
- 3.6 Porter's analysis
- 3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.3 Company matrix analysis
- 4.4 Competitive positioning matrix
- 4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Polymerases and nucleases
- 5.3 Proteases
- 5.4 Oxidases
- 5.5 Carbohydrase
- 5.6 Other products
Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Molecular diagnostics
- 6.3 Immunoassay
- 6.4 Clinical chemistry
- 6.4.1 Blood glucose monitoring
- 6.4.2 POC testing
- 6.4.3 Other clinical chemistry tests
- 6.5 Other applications
Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Netherlands
- 7.3.7 Rest of Europe
- 7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Rest of Asia Pacific
- 7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Rest of Latin America
- 7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE
- 7.6.4 Rest of Middle East and Africa
Chapter 8 Company Profiles
- 8.1 Agilent Technologies, Inc.
- 8.2 Amano Enzymes Inc.
- 8.3 American Laboratories, Inc.
- 8.4 BBI Solutions
- 8.5 Biocatalysts Ltd. (BRAIN Biotech Group)
- 8.6 Bio-Rad Laboratories, Inc.
- 8.7 Codexis, Inc.
- 8.8 F. Hoffmann-La Roche Ltd.
- 8.9 Merck KGaA
- 8.10 New England Biolabs
- 8.11 Novozymes A/S
- 8.12 QIAGEN
- 8.13 SEKISUI Diagnostics
- 8.14 Takara Bio Inc.
- 8.15 Thermo Fisher Scientific Inc.
